Global Health Share Price Prediction 2027: Scenario Targets, Valuation and Technical Outlook
- October 9, 2026
- Posted by: Harsh Piplani
- Category: Market
CMP Rs 1,295.30 (9 Oct 2026). 52W range Rs 956.00 to Rs 1,544.00. PE 62.13. 2027 base Rs 1,554, bull Rs 1,636.
Quick Answer
The Global Health share price forecast for 2027 centres on a conservative case of Rs 1,490, a base case of Rs 1,554 and a bull case of Rs 1,636, against a current price of Rs 1,295.30. These targets scale today’s price by reported EPS growth at a constant PE multiple, so they rest on earnings the company has already delivered, not on broker forecasts. The base case implies 20.0% upside from today’s price. The daily technical setup reads bearish.
Global Health share price prediction 2027 comes down to earnings growth and the multiple investors pay for it, and the reported numbers give a measured answer. The stock trades at Rs 1,295.30 on NSE as of 9 October 2026, 16.1% below its 52-week high of Rs 1,544.00, after the company reported net profit of Rs 554.07 crore for FY26.
This Global Health stock forecast 2027 builds conservative, base and bull scenarios from exchange-reported financials, shareholding data and daily price indicators, with every assumption shown.
Click Here – Get Free Investment Predictions
Global Health Share Price Today and Key Data
The Global Health share price today is Rs 1,295.30 on NSE, up 1.47% on the day. The market capitalisation stands at Rs 34,310 crore. Over the past year the price has fallen 5.8% from Rs 1,374.50. Every Global Health stock forecast figure below starts from this price.
| Metric | Value |
|---|---|
| Company | Global Health (MEDANTA) |
| Current Price | Rs 1,295.30 |
| 52-Week High | Rs 1,544.00 (27 August 2026) |
| 52-Week Low | Rs 956.00 (30 March 2026) |
| Market Cap | Rs 34,310 crore |
| PE Ratio | 62.13 |
| Industry PE | 62.79 |
| PB Ratio | 8.66 |
| EPS (TTM) | Rs 20.54 |
| Return on Equity | 14.05% |
| Debt to Equity | 0.30 |
| Dividend Yield | 0.04% |
| Book Value per Share | Rs 147.34 |
What Is the Global Health Share Price Prediction for 2027?
The Global Health share price prediction for 2027 is a conservative case of Rs 1,490, a base case of Rs 1,554 and a bull case of Rs 1,636. Against Rs 1,295.30, these imply 15.0% upside, 20.0% upside and 26.3% upside. They are model scenarios built from reported EPS growth, not broker targets.
| Scenario | EPS Growth Basis | EPS Estimate | PE Multiple | Implied Value | Upside vs Current Price |
|---|---|---|---|---|---|
| Conservative Case | Lower of FY26 growth (15.3%) and 4-year CAGR (27.7%) (capped at 15%) | Rs 23.62 (+15.0%) | Unchanged from today (price to EPS ratio kept constant) | Rs 1,490 | +15.0% |
| Base Case | Average of the two (capped at 20%) | Rs 24.65 (+20.0%) | Unchanged from today (price to EPS ratio kept constant) | Rs 1,554 | +20.0% |
| Bull Case | Higher of the two (capped at 25%) | Rs 25.67 (+25.0%) | Re-rated 1.1% toward industry PE of 62.79 (still at or below it) | Rs 1,636 | +26.3% |
Each target takes today’s price of Rs 1,295.30 and scales it by the EPS growth assumed for that case, which is the same as holding the PE multiple constant. The conservative case uses the lower of the FY26 EPS growth and the 4-year EPS CAGR, the base case uses their average and the bull case uses the higher figure. The bull case also re-rates the PE multiple toward the industry level, because the stock trades below it. Together they form the Global Health target price range for the FY27 outlook over the next 12 months, and the range is not a point estimate.
Global Health Share Price Forecast: What Has to Go Right by 2027
Each Global Health target price below depends on a specific EPS outcome, and the text states that outcome next to the number.
Conservative Case for the Global Health Share Price Target: Rs 1,490
Reaching Rs 1,490 needs EPS to rise 15.0% to Rs 23.62 while the stock keeps its current PE multiple. That follows the slower 4-year EPS CAGR of 27.7%.
Base Case for the Global Health Share Price Target: Rs 1,554
Reaching Rs 1,554 needs EPS to rise 20.0% to Rs 24.65, the average of the FY26 growth rate and the 4-year CAGR. Net profit growth of -1.1% in Q1 FY27 is below that pace, so earnings need to speed up to reach this level.
Bull Case for the Global Health Share Price Target: Rs 1,636
Reaching Rs 1,636 needs EPS to rise 25.0% to Rs 25.67 and the PE multiple to re-rate 1.1% toward the industry PE. That is above the 52-week high of Rs 1,544.00, so it would need a fresh breakout. A daily close above the nearest resistance level of Rs 1,298.60 (200-day EMA) would be the first technical confirmation.
Global Health Financial Performance: Revenue, Profit and Margins
Global Health earned net profit of Rs 554.07 crore on revenue of Rs 4,508.86 crore in FY26, with profit up 15.1% and revenue up 19.6% compared with FY25. Diluted EPS was Rs 20.66 against Rs 17.92 a year earlier, and that earnings base anchors the Global Health share price forecast.
| Year | Revenue (Rs Cr) | Net Profit (Rs Cr) | EPS (Rs) | Operating Margin | Net Margin |
|---|---|---|---|---|---|
| FY22 | 2,205.82 | 196.20 | 7.77 | 22.91% | 8.89% |
| FY23 | 2,759.16 | 326.08 | 12.57 | 25.30% | 11.82% |
| FY24 | 3,349.78 | 478.06 | 17.80 | 26.98% | 14.27% |
| FY25 | 3,771.29 | 481.32 | 17.92 | 24.79% | 12.76% |
| FY26 | 4,508.86 | 554.07 | 20.66 | 23.30% | 12.29% |
In the latest reported quarter, Q1 FY27 (quarter ended June 2026), revenue was Rs 1,326.21 crore against Rs 1,051.30 crore a year earlier (+26.1%), and the bottom line was a net profit of Rs 157.25 crore against a net profit of Rs 158.98 crore (-1.1%). Operating margin was 23.69% versus 25.90% in the year-ago quarter. Cash flow from operations was Rs 714.39 crore in FY26 against Rs 623.76 crore in FY25. Together these figures set the earnings base for the Global Health share price prediction.
Check the Univest Screener for live Global Health fundamentals
Is Global Health Overvalued or Undervalued Right Now?
Global Health trades at a PE of 62.13 against an industry PE of 62.79, which places the stock in line with the industry average. The price-to-book ratio is 8.66 on a book value of Rs 147.34 per share. Return on equity of 14.05% means the company earns Rs 14.05 of profit for every Rs 100 of shareholder equity.
Debt to equity is 0.30, so borrowings equal about 30% of shareholder equity. The company declared a dividend of Rs 0.50 per share for FY26, a yield of 0.04% at the current price. This valuation context frames the Global Health stock price prediction for 2027 without relying on any outside forecast.
Global Health Stock Analysis: Technical Outlook
Global Health stock trades below its 50-day SMA of Rs 1,426.33 and below its 200-day EMA of Rs 1,298.60, and the combined daily indicators read bearish. The 52-week high of Rs 1,544.00 was set on 27 August 2026, while the 52-week low of Rs 956.00 came on 30 March 2026.
| Indicator | Reading | Signal |
|---|---|---|
| RSI (14) | 15.63 | Oversold |
| MACD (12,26,9) | -38.24 vs signal -17.83 | Bearish |
| ADX (14) | 27.88 | Established trend |
| Supertrend (10,3) | Price below Rs 1,425.10 | Bearish |
| 50-day SMA | Rs 1,426.33 | Price below |
| 200-day EMA | Rs 1,298.60 | Price below |
The nearest support level sits at Rs 956.00 (52-week low). The nearest resistance level sits at Rs 1,298.60 (200-day EMA) and Rs 1,425.10 (Supertrend). A sustained move above the nearest resistance would support the Global Health share price prediction 2027 base case, and this Global Health stock analysis uses daily candles only. Chart signals add context to the Global Health share price target without changing the earnings maths.
Global Health Shareholding Pattern
Promoters hold 33.00% of Global Health as of Jun 2026, down from 33.01% in Jun 2025 across the last 5 quarters. FII holding is 9.46% (down from 11.54% in Jun 2025) and DII holding is 16.89% (up from 12.20% in Jun 2025), which puts combined institutional holding at 26.35%. Public shareholders own 40.65%. Shareholding data is one input for any Global Health stock forecast.
Key Risks to the Global Health Share Price Target for 2027
Earnings and Margin Risk
Operating margin has ranged from 22.91% to 26.98% between FY22 and FY26, so a slip toward the lower end would trim the EPS estimate behind the Global Health stock forecast. Revenue was up 19.6% in FY26, and slower revenue growth would weigh on the profit path.
Size and Liquidity Risk
Market capitalisation stands at Rs 34,310 crore. Investors should check daily traded volumes and order book depth on NSE before sizing a position, because price moves can be sharper when volumes thin out. Liquidity is a practical constraint on any Global Health stock price target.
Balance Sheet Risk
Debt to equity of 0.30 means borrowings stand at about 30% of shareholder equity. A rise in borrowing costs or a jump in debt would weigh on profit and on the multiple behind the Global Health share price forecast.
Technical Risk
The daily indicators read bearish, so the targets above may need a technical turn before the price follows earnings. A daily close below Rs 956.00 (52-week low) would weaken the setup further.
Conclusion
This Global Health stock analysis puts the share price target range for 2027 at Rs 1,490 to Rs 1,636, with a base case of Rs 1,554 against Rs 1,295.30 today. The inputs are a PE of 62.13 that sits in line with the industry average, EPS growth of 15.3% in FY26 and a daily technical setup that reads bearish. The next quarterly result will show which scenario is gaining ground. This analysis is educational, so consult a SEBI-registered advisor before acting on it.
Download the Univest iOS App or Univest Android App to track Global Health live price and get daily stock recommendations.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Global Health Share Price Prediction 2027
What is the Global Health share price target for 2027?
Ans. The Global Health share price forecast for 2027 has a conservative case of Rs 1,490, a base case of Rs 1,554 and a bull case of Rs 1,636. These are model scenarios based on reported EPS growth, and they are not guaranteed outcomes.
What is the Global Health share price today?
Ans. Global Health trades at Rs 1,295.30 on NSE as of 9 October 2026, up 1.47% on the day. The 52-week range is Rs 956.00 to Rs 1,544.00.
Is Global Health a good stock to buy for 2027?
Ans. The data points in different directions: the PE of 62.13 is in line with the industry average, EPS grew 15.3% in FY26 and the daily technical setup reads bearish. This article does not constitute investment advice, so consult a SEBI-registered advisor before deciding.
Can Global Health stock reach Rs 1,636 in 2027?
Ans. Reaching Rs 1,636 needs EPS to rise 25.0% from Rs 20.54 and the PE multiple to re-rate toward the industry PE of 62.79, plus a daily close above Rs 1,298.60 (200-day EMA). This is a scenario, not a guarantee.
What are the support and resistance levels for Global Health?
Ans. The nearest support levels are Rs 956.00 (52-week low), and the nearest resistance levels are Rs 1,298.60 (200-day EMA) and Rs 1,425.10 (Supertrend).
What are the main risks for Global Health stock in 2027?
Ans. The main risks to the Global Health share price forecast are a fall in operating margin from the 22.91% to 26.98% range seen since FY22, slower revenue growth after FY26 revenue was up 19.6%, and thin trading volumes. Debt to equity of 0.30 adds balance sheet sensitivity.
How is the Global Health target price for 2027 calculated?
Ans. Each target scales the current price by assumed EPS growth at a constant PE multiple. The conservative case uses 15.0% growth, the base case 20.0% and the bull case 25.0%, all drawn from the company’s reported FY26 and 4-year EPS growth.
